HK1135691A1 - Camptothecin derivatives with antitumor activity - Google Patents
Camptothecin derivatives with antitumor activityInfo
- Publication number
- HK1135691A1 HK1135691A1 HK10100446.8A HK10100446A HK1135691A1 HK 1135691 A1 HK1135691 A1 HK 1135691A1 HK 10100446 A HK10100446 A HK 10100446A HK 1135691 A1 HK1135691 A1 HK 1135691A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antitumor activity
- camptothecin derivatives
- camptothecin
- derivatives
- antitumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001473A ITMI20061473A1 (it) | 2006-07-26 | 2006-07-26 | Derivati della camptotecina ad attivita antitumorale |
| PCT/EP2007/006243 WO2008011994A1 (en) | 2006-07-26 | 2007-07-13 | Camptothecin derivatives with antitumor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1135691A1 true HK1135691A1 (en) | 2010-06-11 |
Family
ID=38668829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10100446.8A HK1135691A1 (en) | 2006-07-26 | 2010-01-15 | Camptothecin derivatives with antitumor activity |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8217053B2 (ko) |
| EP (1) | EP2044079B1 (ko) |
| JP (1) | JP5313894B2 (ko) |
| KR (1) | KR101412157B1 (ko) |
| CN (1) | CN101495486B (ko) |
| AU (1) | AU2007278500B2 (ko) |
| BR (1) | BRPI0714553B8 (ko) |
| CA (1) | CA2658900C (ko) |
| DK (1) | DK2044079T3 (ko) |
| ES (1) | ES2561356T3 (ko) |
| HK (1) | HK1135691A1 (ko) |
| HU (1) | HUE027890T2 (ko) |
| IL (1) | IL196653A (ko) |
| IT (1) | ITMI20061473A1 (ko) |
| MX (1) | MX2009000827A (ko) |
| NO (1) | NO341812B1 (ko) |
| PL (1) | PL2044079T3 (ko) |
| PT (1) | PT2044079E (ko) |
| RU (1) | RU2450008C2 (ko) |
| SI (1) | SI2044079T1 (ko) |
| WO (1) | WO2008011994A1 (ko) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2907824T (pt) | 2012-10-11 | 2018-06-07 | Daiichi Sankyo Co Ltd | Conjugado de anticorpo-fármaco |
| WO2014061277A1 (ja) | 2012-10-19 | 2014-04-24 | 第一三共株式会社 | 親水性構造を含むリンカーで結合させた抗体－薬物コンジュゲート |
| KR101586030B1 (ko) * | 2014-01-22 | 2016-01-15 | 주식회사 엘지생활건강 | 캄프토테신을 유효성분으로 포함하는 체모 성장 억제용 조성물 |
| KR102275925B1 (ko) | 2014-01-31 | 2021-07-12 | 다이이찌 산쿄 가부시키가이샤 | 항-her2 항체-약물 접합체 |
| HUE061408T2 (hu) | 2015-06-29 | 2023-06-28 | Daiichi Sankyo Co Ltd | Eljárás antitest-gyógyszer konjugátum szelektív elõállítására |
| SG10201912575RA (en) | 2016-12-12 | 2020-02-27 | Daiichi Sankyo Co Ltd | Combination of antibody-drug conjugate and immune checkpoint inhibitor |
| TWI780104B (zh) | 2017-01-17 | 2022-10-11 | 日商第一三共股份有限公司 | 抗ｇｐｒ２０抗體及抗ｇｐｒ２０抗體-藥物結合物、以及其製造方法及用途 |
| TWI794230B (zh) | 2017-05-15 | 2023-03-01 | 日商第一三共股份有限公司 | 抗ｃｄｈ６抗體及抗ｃｄｈ６抗體-藥物結合物、以及其製造方法 |
| SG11202001514XA (en) | 2017-08-31 | 2020-03-30 | Daiichi Sankyo Co Ltd | Novel method for producing antibody-drug conjugate |
| CN111051330A (zh) | 2017-08-31 | 2020-04-21 | 第一三共株式会社 | 抗体-药物缀合物的改进制备方法 |
| US20210221910A1 (en) | 2018-05-18 | 2021-07-22 | Glycotope Gmbh | Anti-muc1 antibody |
| US10568873B1 (en) * | 2019-02-14 | 2020-02-25 | United Arab Emirates University | Safranal-sorafenib combination therapy for liver cancer |
| CN112905237A (zh) | 2019-12-04 | 2021-06-04 | 北京百度网讯科技有限公司 | 指令预取方法、装置、设备和介质 |
| CN112225745B (zh) * | 2020-11-16 | 2021-10-12 | 烟台大学 | 一种具有抗肿瘤活性的异片螺素类化合物、制备方法及用途 |
| CN117510515A (zh) * | 2022-07-28 | 2024-02-06 | 明慧医药（杭州）有限公司 | 适用于抗体-药物偶联物的毒素分子 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
| US5972955A (en) * | 1995-06-06 | 1999-10-26 | Dr. Reddy's Research Foundation | Water soluble C-ring analogues of 20(S)-camptothecin |
| FR2757515B1 (fr) * | 1996-12-20 | 2000-05-05 | Sod Conseils Rech Applic | Formes prodrogues et nouveaux analogues de la camptothecine, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| US6881555B2 (en) * | 1999-03-19 | 2005-04-19 | Aventis Pharmaceuticals Inc. | AKT nucleic acids, polypeptides, and uses thereof |
| PL368229A1 (en) * | 2001-09-25 | 2005-03-21 | Dr.Reddy's Laboratories Limited | Pharmaceutically acceptable salts of 20(s)-camptothecins |
| US20060084167A1 (en) * | 2004-10-16 | 2006-04-20 | Cohenford Menashi A | Formation of Hybrid Cells by Fusion of Lineage Committed Cells with Stem Cells |
-
2006
- 2006-07-26 IT IT001473A patent/ITMI20061473A1/it unknown
-
2007
- 2007-07-13 US US12/374,963 patent/US8217053B2/en active Active
- 2007-07-13 EP EP07786063.3A patent/EP2044079B1/en active Active
- 2007-07-13 ES ES07786063.3T patent/ES2561356T3/es active Active
- 2007-07-13 HU HUE07786063A patent/HUE027890T2/en unknown
- 2007-07-13 CA CA2658900A patent/CA2658900C/en not_active Expired - Fee Related
- 2007-07-13 RU RU2009102243/04A patent/RU2450008C2/ru active
- 2007-07-13 KR KR1020097001595A patent/KR101412157B1/ko active IP Right Grant
- 2007-07-13 PL PL07786063T patent/PL2044079T3/pl unknown
- 2007-07-13 BR BRPI0714553A patent/BRPI0714553B8/pt not_active IP Right Cessation
- 2007-07-13 PT PT77860633T patent/PT2044079E/pt unknown
- 2007-07-13 AU AU2007278500A patent/AU2007278500B2/en not_active Ceased
- 2007-07-13 JP JP2009521137A patent/JP5313894B2/ja not_active Expired - Fee Related
- 2007-07-13 MX MX2009000827A patent/MX2009000827A/es active IP Right Grant
- 2007-07-13 SI SI200731737T patent/SI2044079T1/sl unknown
- 2007-07-13 DK DK07786063.3T patent/DK2044079T3/en active
- 2007-07-13 WO PCT/EP2007/006243 patent/WO2008011994A1/en active Application Filing
- 2007-07-13 CN CN2007800283564A patent/CN101495486B/zh active Active
-
2009
- 2009-01-16 NO NO20090251A patent/NO341812B1/no not_active IP Right Cessation
- 2009-01-22 IL IL196653A patent/IL196653A/en active IP Right Grant
-
2010
- 2010-01-15 HK HK10100446.8A patent/HK1135691A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101495486A (zh) | 2009-07-29 |
| AU2007278500A2 (en) | 2010-09-09 |
| BRPI0714553B1 (pt) | 2020-11-17 |
| PT2044079E (pt) | 2016-03-09 |
| RU2009102243A (ru) | 2010-07-27 |
| US8217053B2 (en) | 2012-07-10 |
| NO20090251L (no) | 2009-01-16 |
| PL2044079T3 (pl) | 2016-06-30 |
| AU2007278500B2 (en) | 2012-06-07 |
| KR101412157B1 (ko) | 2014-06-25 |
| CA2658900C (en) | 2015-09-15 |
| AU2007278500A1 (en) | 2008-01-31 |
| JP2009544634A (ja) | 2009-12-17 |
| SI2044079T1 (sl) | 2016-02-29 |
| ES2561356T3 (es) | 2016-02-25 |
| DK2044079T3 (en) | 2016-02-29 |
| HUE027890T2 (en) | 2016-11-28 |
| MX2009000827A (es) | 2009-02-03 |
| JP5313894B2 (ja) | 2013-10-09 |
| BRPI0714553A2 (pt) | 2013-03-26 |
| WO2008011994A1 (en) | 2008-01-31 |
| BRPI0714553B8 (pt) | 2021-05-25 |
| EP2044079B1 (en) | 2015-12-09 |
| IL196653A (en) | 2015-04-30 |
| NO341812B1 (no) | 2018-01-29 |
| ITMI20061473A1 (it) | 2008-01-27 |
| CA2658900A1 (en) | 2008-01-31 |
| EP2044079A1 (en) | 2009-04-08 |
| KR20090033456A (ko) | 2009-04-03 |
| CN101495486B (zh) | 2013-05-15 |
| RU2450008C2 (ru) | 2012-05-10 |
| US20100120816A1 (en) | 2010-05-13 |
| IL196653A0 (en) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1135691A1 (en) | Camptothecin derivatives with antitumor activity | |
| HK1129100A1 (en) | Coumarin derivative having antitumor activity | |
| IL193175A0 (en) | Pyridine-2-carboxamide derivatives | |
| IL194367A0 (en) | Dihydropyrazolopyrimidinone derivatives | |
| HK1134284A1 (en) | Pyridizinone derivatives pyridizinone | |
| IL193641A0 (en) | Spiroindolinone derivatives | |
| IL195013A0 (en) | Pyridopyrimidinone derivatives | |
| EP1973405A4 (en) | HYDROXYALKYMARYLAMIDE DERIVATIVES | |
| IL198319A0 (en) | Spiroindolinone derivatives | |
| IL195422A0 (en) | 2-pyrazinecarboxamide derivatives | |
| IL192401A0 (en) | Indol-3-yl-carbonyl-spiro-piperidine derivatives | |
| IL198059A0 (en) | 2-aminocarbonyl-pyridine derivatives | |
| IL196364A0 (en) | Aminoindazolylurea derivatives | |
| GB0625842D0 (en) | Indolizine derivatives | |
| HK1136276A1 (en) | 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2- | |
| IL193211A0 (en) | Indazole-heteroaryl derivatives | |
| ZA200903175B (en) | Spiro-piperidine derivatives | |
| EP2228376A4 (en) | PYRIPYROPEN DERIVATIVE WITH ACAT2-HEMMENDER EFFECT | |
| IL197152A0 (en) | 5-phenyl-nicotinamide derivatives | |
| EP2043633A4 (en) | THIADIAZOLIDINONDERIVATE | |
| ZA200901034B (en) | Avermectin derivatives | |
| HK1135692A1 (en) | Camptothecin derivatives with antitumor activity | |
| TWI339663B (en) | Spiro-piperidine derivatives | |
| IL197239A0 (en) | Phenyloxyaniline derivatives | |
| IL184113A0 (en) | Indole derivatives with antitumor activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210713 |